Institutional investors purchased a net $5.1 million shares of NEO during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 58.53% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RUSSELL INVESTMENT MANAGEMENT LL... Bought 1.6 Million shares of Neogenomics Inc
NEXT CENTURY GROWTH INVESTORS LL... Bought 1.6 Million shares of Neogenomics Inc
BLACKROCK FUND ADVISORS Bought 572.3 Thousand shares of Neogenomics Inc